Sandbox Reserved 1227
From Proteopedia
(Difference between revisions)
Line 4: | Line 4: | ||
== Function == | == Function == | ||
- | + | Mdm2 is an E3 ubiquitin ligase that ubiquitylates and targets p53 for degradation. MDM2 and MDM4, a closely related protein to MDM2, are two of the main inhibitory proteins of the p53 pathway. The p53 pathway is the one that is activated when the cell is distressed. The p53 pathway leads to the ceasing of proliferation of the cell, or by causing cell death. The interaction between MDM4 and p53 can be seen in <scene name='75/750276/Mdm4-p53_interaction/1'>p53-MDM4 interaction</scene>. On the other hand, if MDM2 or MDM4 is under regulated, p53 will overwork, causing cell death more often and earlier on than necessary.<ref>Eischen, C. M., & Lozano, G. (2014). The Mdm network and its regulation of p53 activities: a rheostat of cancer risk. Human Mutation, 35(6), 728–737. http://doi.org/10.1002/humu.22524</ref> | |
+ | |||
+ | Data involving MDM2 and the SNP285 polymorphism within its promotor region have been researched and is significantly linked to a decreased cancer risk<ref>Wang, P., Wang, M., Li, S., Ma, L., Xi, S., & He, J. (2016). Association of the MDM2 SNP285 Polymorphism with Cancer Susceptibility: A Meta-Analysis. Disease Markers, 20164585484.</ref>. | ||
== Relevance == | == Relevance == |
Revision as of 20:11, 24 April 2017
This Sandbox is Reserved from Jan 17 through June 31, 2017 for use in the course Biochemistry II taught by Jason Telford at the Maryville University, St. Louis, USA. This reservation includes Sandbox Reserved 1225 through Sandbox Reserved 1244. |
To get started:
More help: Help:Editing |
MDM2
|
References
- ↑ Eischen, C. M., & Lozano, G. (2014). The Mdm network and its regulation of p53 activities: a rheostat of cancer risk. Human Mutation, 35(6), 728–737. http://doi.org/10.1002/humu.22524
- ↑ Wang, P., Wang, M., Li, S., Ma, L., Xi, S., & He, J. (2016). Association of the MDM2 SNP285 Polymorphism with Cancer Susceptibility: A Meta-Analysis. Disease Markers, 20164585484.
- ↑ Eischen, C. M., & Lozano, G. (2014). The Mdm network and its regulation of p53 activities: a rheostat of cancer risk. Human Mutation, 35(6), 728–737. http://doi.org/10.1002/humu.22524
- ↑ Wang, P., Wang, M., Li, S., Ma, L., Xi, S., & He, J. (2016). Association of the MDM2 SNP285 Polymorphism with Cancer Susceptibility: A Meta-Analysis. Disease Markers, 20164585484.
- ↑ Trino, S., De Luca, L., Laurenzana, I., Caivano, A., Del Vecchio, L., Martinelli, G., & Musto, P. (2016). P53-MDM2 Pathway: Evidences for A New Targeted Therapeutic Approach in B-Acute Lymphoblastic Leukemia. Frontiers in Pharmacology, 7, 491. http://doi.org/10.3389/fphar.2016.00491.
- ↑ Ciemny, M. P., Debinski, A., Paczkowska, M., Kolinski, A., Kurcinski, M., & Kmiecik, S. (2016). Protein-peptide molecular docking with large-scale conformational changes: the p53-MDM2 interaction. Scientific Reports, 6, 37532. http://doi.org/10.1038/srep37532.